Mark T Reding

12PUBLICATIONS
50CO-AUTHORS
HaematologyEpidemiological modellingImplementation science and evaluationForensic epidemiologyOccupational epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Mar 26, 2026
A New Risk-Based Scoring Approach to Individualize Prophylaxis in Patients with Hemophilia A: Results from the PREDICT Study.

Doris V Quon, Miguel Escobar, Lisa Boggio

|Oct 17, 2025
Characterization and management of patients with hereditary factor X deficiency: A case series.

Meera Chitlur, Lauren E Amos, Mark T Reding

|Apr 28, 2023
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study.

Mark T Reding, Ingrid Pabinger, Pål Andrè Holme

|Oct 12, 2022
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature.

Alfonso Iorio, Christoph Königs, Mark T Reding

|Oct 06, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.

Miguel Escobar, James Luck, Yevhenii Averianov

|Sep 22, 2021
Implementation of an Anticoagulation Practice Guideline for COVID-19 via a Clinical Decision Support System in a Large Academic Health System and Its Evaluation: Observational Study.

Surbhi Shah, Sean Switzer, Nathan D Shippee

Pageof 2

Frequent Collaborators

2 joint publications

Miguel Escobar

2 joint publications

Maria Elisa Mancuso

2 joint publications

Elena Santagostino

2 joint publications

Ingrid Pabinger